- NEW PATIENTS
- Cosmetic Dentistry
- Implant Dentistry
- Oral Surgery
- Other Services
- About ODG
ViziLite® Plus is the first adjunctive oral cancer screening system that was developed to help oral healthcare professionals identify, evaluate, monitor and mark abnormal oral cell lesions suspicious for pathology including precancerous and cancerous cells that may be difficult to see during a regular visual exam.
— NO FALSE NEGATIVE OUTCOMES, meaning in this clinical study ViziLite® Plus with TBlue® identified every lesion that had precancerous or cancerous cells.
— SIGNIFICANTLY REDUCED the number of false positive lesions identified during standard visual examinations – limiting the number of biopsies that may have normally been performed.